Alnylam Pharmaceuticals
ALNY
#439
Rank
$53.86 B
Marketcap
$407.73
Share price
1.87%
Change (1 day)
68.30%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company